Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injury.
- DOI
- 10.1007/s11302-017-9558-3
- Published
- 2017 Jun
- Container
- Purinergic signalling
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s11302-017-9558-3,
title = {Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injury.},
author = {Sashindranath M and Dwyer KM and Dezfouli S and Selan C and Crikis S and Lu B and Yuan Y and Hickey MJ and Peter K and Robson SC and Cowan PJ and Nandurkar HH},
year = {2017},
journal = {Purinergic signalling},
doi = {10.1007/s11302-017-9558-3},
url = {https://doi.org/10.1007/s11302-017-9558-3}
}RIS
TY - JOUR TI - Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injury. AU - Sashindranath M AU - Dwyer KM AU - Dezfouli S AU - Selan C AU - Crikis S AU - Lu B AU - Yuan Y AU - Hickey MJ AU - Peter K AU - Robson SC AU - Cowan PJ AU - Nandurkar HH PY - 2017 JO - Purinergic signalling DO - 10.1007/s11302-017-9558-3 UR - https://doi.org/10.1007/s11302-017-9558-3 ER -
APA
M, S., KM, D., S, D., C, S., S, C., B, L., Y, Y., MJ, H., K, P., SC, R., PJ, C., & HH, N. (2017). Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injury.. Purinergic signalling. https://doi.org/10.1007/s11302-017-9558-3
Source records
- pubmed · retrieved 2026-09-26T10:58:58.681Z